Drugs Made In America Acquisition Corp. - Ordinary Shares
Drugs Made In America Acquisition Corp. - Ordinary Shares
Share · KYG2847J1040 · DMAA (XNAS)
Overview
No Price
04.11.2025 21:00
Current Prices from Drugs Made In America Acquisition Corp. - Ordinary Shares
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
DMAA
USD
04.11.2025 21:00
10,33 USD
0,01 USD
+0,15 %
Share Float & Liquidity
Free Float 86,31 %
Shares Float 28,93 M
Shares Outstanding 33,52 M
Company Profile for Drugs Made In America Acquisition Corp. - Ordinary Shares Share
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Get up to date insights from finAgent about Drugs Made In America Acquisition Corp. - Ordinary Shares

Company Data

Name Drugs Made In America Acquisition Corp. - Ordinary Shares
Company Drugs Made In America Acquisition Corp. Ordinary Shares
Symbol DMAA
Website https://dmaacorp.com
Primary Exchange XNAS NASDAQ
ISIN KYG2847J1040
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO Lynn Stockwell
Market Capitalization 346 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 1 East Broward Blvd Suite 700, 33301 Fort Lauderdale
IPO Date 2025-01-27

Ticker Symbols

Name Symbol
NASDAQ DMAA
More Shares
Investors who hold Drugs Made In America Acquisition Corp. - Ordinary Shares also have the following shares in their portfolio:
BK MONTREAL 20/23 FLR MTN
BK MONTREAL 20/23 FLR MTN Bond
Simplify Exchange Traded Funds Simplify Market Neutral Equity Long/Short ETF
Simplify Exchange Traded Funds Simplify Market Neutral Equity Long/Short ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025